DK3230255T3 - Regulatorer af uhæmmet adfærd - Google Patents
Regulatorer af uhæmmet adfærd Download PDFInfo
- Publication number
- DK3230255T3 DK3230255T3 DK15867070.3T DK15867070T DK3230255T3 DK 3230255 T3 DK3230255 T3 DK 3230255T3 DK 15867070 T DK15867070 T DK 15867070T DK 3230255 T3 DK3230255 T3 DK 3230255T3
- Authority
- DK
- Denmark
- Prior art keywords
- regulators
- disabled
- behavior
- disabled behavior
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12C—BEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
- C12C5/00—Other raw materials for the preparation of beer
- C12C5/02—Additives for beer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G2200/00—Special features
- C12G2200/21—Wine additives, e.g. flavouring or colouring agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Addiction (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Food Science & Technology (AREA)
- Neurology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462089500P | 2014-12-09 | 2014-12-09 | |
| US201462089504P | 2014-12-09 | 2014-12-09 | |
| PCT/IL2015/051193 WO2016092546A1 (en) | 2014-12-09 | 2015-12-09 | Binge behavior regulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3230255T3 true DK3230255T3 (da) | 2020-06-22 |
Family
ID=56286452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15867070.3T DK3230255T3 (da) | 2014-12-09 | 2015-12-09 | Regulatorer af uhæmmet adfærd |
Country Status (5)
| Country | Link |
|---|---|
| US (7) | US10137096B2 (da) |
| EP (2) | EP3230255B1 (da) |
| CN (2) | CN107406369B (da) |
| DK (1) | DK3230255T3 (da) |
| WO (1) | WO2016092546A1 (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016092547A1 (en) | 2014-12-09 | 2016-06-16 | Ezekiel Golan | Alcoholic beverage substitutes |
| CN107406369B (zh) | 2014-12-09 | 2021-01-15 | 以西结·戈兰 | 放纵行为调节剂 |
| WO2021252538A2 (en) | 2020-06-08 | 2021-12-16 | Tactogen Inc | Advantageous benzofuran compositions for mental disorders or enhancement |
| TW202216676A (zh) | 2020-07-06 | 2022-05-01 | 美商塔朵根公司 | 用於心理疾病或心理強化的有益苯并噻吩組合物 |
| CN116209657A (zh) | 2020-08-06 | 2023-06-02 | 泰科根公司 | 用于精神障碍或增强的2-氨基茚满化合物 |
| EP4337316A1 (en) | 2021-05-11 | 2024-03-20 | Awakn Ls Europe Holdings Limited | Therapeutic aminoindane compounds and compositions |
| WO2023092044A2 (en) | 2021-11-17 | 2023-05-25 | Terran Biosciences, Inc. | Phenethylamine compounds salts, polymorphic forms and methods of use thereof |
| CA3244360A1 (en) * | 2022-03-07 | 2023-09-14 | Clearmind Medicine Inc. | Compositions containing MEAI and N-acylethanolamines and their uses |
| CA3253569A1 (en) * | 2022-06-01 | 2023-12-07 | Clearmind Medicine Inc. | USE OF 5-METHOXY-2-AMINOINDANE ("MEAI") IN METHODS OF TREATMENT FOR COCAINE ADDICTION |
| WO2024201245A1 (en) * | 2023-03-29 | 2024-10-03 | Clearmind Medicine Inc. | Compositions comprising 5-methoxy-2-aminoindan for treatment of depression |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2712998A (en) | 1952-09-20 | 1955-07-12 | Vosseler Otto | Process for the production of a fermentation beverage |
| DE952441C (de) * | 1954-06-10 | 1956-11-15 | Schering Ag | Verfahren zur Herstellung von analgetisch wirksamen 2-Aminoindanverbindungen |
| US4160452A (en) | 1977-04-07 | 1979-07-10 | Alza Corporation | Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina |
| US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| US4990350A (en) | 1990-01-16 | 1991-02-05 | Joseph E. Seagrams And Sons, Inc. | Process for preparing reduced alcoholic spirits and the product produced therefrom |
| WO1995004713A1 (en) * | 1993-08-06 | 1995-02-16 | The Upjohn Company | 2-aminoindans as selective dopamine d3 ligands |
| SE9703379D0 (sv) | 1997-09-18 | 1997-09-18 | Astra Ab | New compounds |
| UA58476C2 (uk) * | 1997-10-09 | 2003-08-15 | Санофі-Сентелябо | Похідні 8-азабіцикло[3.2.1]октан-3-метанаміну, фармацевтична композиція та лікарський засіб |
| WO2001034172A2 (en) * | 1999-11-05 | 2001-05-17 | Vela Pharmaceuticals Inc. | Methods and compositions for treating reward deficiency syndrome |
| TWI243164B (en) * | 2001-02-13 | 2005-11-11 | Aventis Pharma Gmbh | Acylated indanyl amines and their use as pharmaceuticals |
| US6933410B2 (en) | 2002-03-08 | 2005-08-23 | Novartis Ag | Process for preparing 5,6-diethyl-2,3-dihydro-1H-inden-2-amine |
| CA2503405A1 (en) * | 2002-10-21 | 2004-05-06 | Janssen Pharmaceutica, N.V. | Treating syndrome x with substituted tetralins and indanes |
| EP1944289B1 (en) | 2004-08-09 | 2010-05-19 | Glaxo Group Limited | Compounds which potentiate glutamate receptor and uses thereof in medicine |
| WO2007069925A2 (en) | 2005-12-18 | 2007-06-21 | Stargate International Limited | Non-neurotoxic recreational drugs and a method of treating recreational drug abuse |
| WO2008021849A2 (en) * | 2006-08-09 | 2008-02-21 | Smithkline Beecham Corporation | Novel compounds as antagonists or inverse agonists at opioid receptors |
| EP2556830A1 (en) | 2006-12-19 | 2013-02-13 | University Of Virginia Patent Foundation | Combined effects of topiramate, ondansetron and naltrexone on alcohol consumption |
| KR101062376B1 (ko) | 2008-04-10 | 2011-09-06 | 한국화학연구원 | 신규 인돌 카르복실산 비스피리딜 카르복사마이드 유도체,이의 제조방법 및 이를 유효성분으로 함유하는 조성물 |
| US20100113512A1 (en) | 2008-10-30 | 2010-05-06 | Diane Michele Ignar | Method of treatment using novel antagonists or inverse agonists at opioid receptors |
| JP5890951B2 (ja) | 2010-09-13 | 2016-03-22 | ベヴ−アールエックス、インク． | 不快味マスキング剤を有する水性薬物送達システム |
| CN107406369B (zh) | 2014-12-09 | 2021-01-15 | 以西结·戈兰 | 放纵行为调节剂 |
| WO2016092547A1 (en) | 2014-12-09 | 2016-06-16 | Ezekiel Golan | Alcoholic beverage substitutes |
-
2015
- 2015-12-09 CN CN201580075677.4A patent/CN107406369B/zh active Active
- 2015-12-09 EP EP15867070.3A patent/EP3230255B1/en active Active
- 2015-12-09 US US15/534,137 patent/US10137096B2/en active Active
- 2015-12-09 DK DK15867070.3T patent/DK3230255T3/da active
- 2015-12-09 CN CN202011545936.4A patent/CN112500301B/zh active Active
- 2015-12-09 WO PCT/IL2015/051193 patent/WO2016092546A1/en not_active Ceased
- 2015-12-09 EP EP20161755.2A patent/EP3705469A1/en active Pending
-
2018
- 2018-10-23 US US16/167,576 patent/US10406123B2/en not_active Expired - Fee Related
-
2019
- 2019-09-09 US US16/563,974 patent/US11077072B2/en active Active
-
2021
- 2021-07-09 US US17/371,511 patent/US12064402B2/en active Active
- 2021-07-09 US US17/371,626 patent/US12357590B2/en active Active
- 2021-07-09 US US17/371,564 patent/US12350242B2/en active Active
-
2025
- 2025-06-04 US US19/228,436 patent/US20250288541A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3230255B1 (en) | 2020-03-18 |
| US20210330608A1 (en) | 2021-10-28 |
| CN107406369B (zh) | 2021-01-15 |
| US10137096B2 (en) | 2018-11-27 |
| US20210330607A1 (en) | 2021-10-28 |
| US11077072B2 (en) | 2021-08-03 |
| EP3230255A1 (en) | 2017-10-18 |
| US20200000747A1 (en) | 2020-01-02 |
| US20180085326A1 (en) | 2018-03-29 |
| US10406123B2 (en) | 2019-09-10 |
| WO2016092546A1 (en) | 2016-06-16 |
| US12350242B2 (en) | 2025-07-08 |
| US20210330609A1 (en) | 2021-10-28 |
| US20250288541A1 (en) | 2025-09-18 |
| CN112500301A (zh) | 2021-03-16 |
| EP3230255A4 (en) | 2018-08-01 |
| US20190054042A1 (en) | 2019-02-21 |
| US12357590B2 (en) | 2025-07-15 |
| EP3705469A1 (en) | 2020-09-09 |
| CN112500301B (zh) | 2024-02-13 |
| CN107406369A (zh) | 2017-11-28 |
| US12064402B2 (en) | 2024-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3137169T3 (da) | Hæmmere af lysin-specifik demethylase-1 | |
| DK3851537T3 (da) | Behandling af hyperbilirubinæmi | |
| DK3102576T3 (da) | Dihydropyrrolopyridininhibitorer af ror-gamma | |
| DK3192902T3 (da) | Fremgangsmåde til fremstilling af graphenholdige viscosefibre | |
| DK3164380T3 (da) | Hæmmere af lysinspecifik demethylase-1 | |
| DK3180331T3 (da) | Polymorfer af selinexor | |
| EP4015535C0 (en) | GLYCO-ENGINEERING MODIFICATION OF SITE-SPECIFIC TARGETING MOIETIES | |
| DK3160956T3 (da) | Inhibitorer af lysin-specifik demethylase-1 | |
| DK3461891T3 (da) | Nedstrømsbehandling af en alkalisk phosphatase | |
| DK3230255T3 (da) | Regulatorer af uhæmmet adfærd | |
| IL263050B (en) | Derivatives of sobetirome | |
| DK3132009T3 (da) | Fremgangsmåde | |
| DK3220891T3 (da) | Sublingual formulering af riluzol | |
| DK3175012T3 (da) | Forbedret aktivering af selvpassiverende metaller | |
| DK3283210T3 (da) | Fremgangsmåde | |
| DK3418273T3 (da) | Derivater af flavagliner | |
| DK3204352T3 (da) | Hæmmere af lysin-gingipain | |
| DK3307267T3 (da) | Behandling af multipel sklerose | |
| DK3113773T3 (da) | Krystallinske former af grapiprant | |
| DK2897382T3 (da) | Forbedring af binaural kilde | |
| DK3297619T3 (da) | Terapeutiske anvendelser af L-4-chlorkynurenin | |
| IL254502A0 (en) | Solid forms of menaquinols | |
| DK3201323T3 (da) | Modificering af bakteriofag | |
| DK2910535T3 (da) | Sammensætning til anvendelse af ekspanderet perlit | |
| DK3430004T3 (da) | Faststofformer af nilotinibsalte |